414 related articles for article (PubMed ID: 36849958)
1. Metformin and long non-coding RNAs in breast cancer.
Gholami M; Klashami ZN; Ebrahimi P; Mahboobipour AA; Farid AS; Vahidi A; Zoughi M; Asadi M; Amoli MM
J Transl Med; 2023 Feb; 21(1):155. PubMed ID: 36849958
[TBL] [Abstract][Full Text] [Related]
2. Effect of metformin on the long non-coding RNA expression levels in type 2 diabetes: an in vitro and clinical trial study.
Parvar SN; Mirzaei A; Zare A; Doustimotlagh AH; Nikooei S; Arya A; Alipoor B
Pharmacol Rep; 2023 Feb; 75(1):189-198. PubMed ID: 36334247
[TBL] [Abstract][Full Text] [Related]
3. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer.
Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R
J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.
Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L
Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNAs as novel prognostic biomarkers for breast cancer in Egyptian women.
El-Helkan B; Emam M; Mohanad M; Fathy S; Zekri AR; Ahmed OS
Sci Rep; 2022 Nov; 12(1):19498. PubMed ID: 36376369
[TBL] [Abstract][Full Text] [Related]
6. Exosomal Long Non-Coding RNAs in Lung Diseases.
Poulet C; Njock MS; Moermans C; Louis E; Louis R; Malaise M; Guiot J
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438606
[TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
8. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
9. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
10. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract][Full Text] [Related]
11. Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer.
Özgür E; Ferhatoğlu F; Şen F; Saip P; Gezer U
Cancer Biomark; 2020; 27(1):11-17. PubMed ID: 31640083
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of long non-coding RNA-based biomarkers in the urinary sediment and urinary exosomes for non-invasive diagnosis of bladder cancer.
Qiu T; Xue M; Li X; Li F; Liu S; Yao C; Chen W
Mol Omics; 2022 Dec; 18(10):938-947. PubMed ID: 36164958
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of lncRNAs in breast cancer: Meta-analysis shows no association with susceptibility.
Mathias C; Garcia LE; Teixeira MD; Kohler AF; Marchi RD; Barazetti JF; Gradia DF; de Oliveira JC
J Gene Med; 2020 Dec; 22(12):e3271. PubMed ID: 32889751
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of long non-coding RNAs with a potential role in breast cancer.
Heidari R; Akbariqomi M; Asgari Y; Ebrahimi D; Alinejad-Rokny H
Mutat Res Rev Mutat Res; 2021; 787():108375. PubMed ID: 34083033
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?
Mathias C; Zambalde EP; Rask P; Gradia DF; de Oliveira JC
Clin Genet; 2019 May; 95(5):558-568. PubMed ID: 30614523
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
[TBL] [Abstract][Full Text] [Related]
17. Microarray expression profile analysis of long non-coding RNAs in human breast cancer: a study of Chinese women.
Xu N; Wang F; Lv M; Cheng L
Biomed Pharmacother; 2015 Feb; 69():221-7. PubMed ID: 25661361
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis.
Gao S; Zhao ZY; Wu R; Zhang Y; Zhang ZY
Onco Targets Ther; 2018; 11():4877-4891. PubMed ID: 30147339
[TBL] [Abstract][Full Text] [Related]
19. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
